SIC 2836
Biological Products, (No Diagnostic Substances)
145 companies · 0 with disclosed financials
Total revenue (latest)
—
Total net income
—
Avg net margin
—
Median net margin
—
5-year industry trend
Total revenue summed across 93 companies in the most recent fiscal year. Median margin is the cross-sectional median per year.
Largest by revenue
- 1ABPWWAbpro Holdings, Inc.
$20.0K cap
—
revenue
- 2ABOSAcumen Pharmaceuticals, Inc.
$181.3M cap
—
revenue
- 3KYTXKyverna Therapeutics, Inc.
$527.1M cap
—
revenue
- 4TECXTectonic Therapeutic, Inc.
$549.5M cap
—
revenue
- 5DNAGinkgo Bioworks Holdings, Inc.
$518.6M cap
—
revenue
- 6HALOHALOZYME THERAPEUTICS, INC.
$8.10B cap
—
revenue
- 7CADLCandel Therapeutics, Inc.
$585.4M cap
—
revenue
- 8CHRSCoherus Oncology, Inc.
$248.3M cap
—
revenue
- 9RVMDRevolution Medicines, Inc.
$32.22B cap
—
revenue
- 10CCCCC4 Therapeutics, Inc.
$393.6M cap
—
revenue
- 11GILDGILEAD SCIENCES, INC.
$166.82B cap
—
revenue
- 12VYGRVoyager Therapeutics, Inc.
$229.6M cap
—
revenue
- 13RGENREPLIGEN CORP
$6.49B cap
—
revenue
- 14NBIXNEUROCRINE BIOSCIENCES INC
$15.76B cap
—
revenue
- 15EXELEXELIXIS, INC.
$12.61B cap
—
revenue
- 16CGONCG Oncology, Inc.
$5.67B cap
—
revenue
- 17APGEApogee Therapeutics, Inc.
$6.08B cap
—
revenue
- 18IBRXImmunityBio, Inc.
$7.56B cap
—
revenue
- 19REPLReplimune Group, Inc.
$405.4M cap
—
revenue
- 20SRRKScholar Rock Holding Corp
$5.77B cap
—
revenue
- 21IMVTImmunovant, Inc.
$7.01B cap
—
revenue
- 22TARSTarsus Pharmaceuticals, Inc.
$2.68B cap
—
revenue
- 23ZEOXZeo ScientifiX, Inc.
$15.4M cap
—
revenue
- 24RLAYRelay Therapeutics, Inc.
$2.59B cap
—
revenue
- 25INBXInhibrx Biosciences, Inc.
$1.49B cap
—
revenue
Insider activity in this industry · last 12 months
Insider buying
$835.1M
Insider selling
$777.3M
Net flow
+$57.8M
Distinct insiders
152
Open-market trades summed across all 12 companies in the industry where insiders bought. Sales counted across all companies regardless. Filed via SEC Form 4.
Recently filed in this industry
Related industries
Pharmaceutical Preparations
SIC 2834 · 75 cos
Industrial Organic Chemicals
SIC 2860 · 5 cos
Chemicals & Allied Products
SIC 2800 · 4 cos
Plastic Material, Synth Resin/Rubber, Cellulos (No Glass)
SIC 2820 · 2 cos
Plastic Materials, Synth Resins & Nonvulcan Elastomers
SIC 2821 · 2 cos
Miscellaneous Chemical Products
SIC 2890 · 2 cos
Agricultural Chemicals
SIC 2870 · 1 cos
Medicinal Chemicals & Botanical Products
SIC 2833 · 1 cos
About the Biological Products, (No Diagnostic Substances) industry on ActaClear
ActaClear tracks 145 US-listed public companies classified under SEC SIC code 2836 (Biological Products, (No Diagnostic Substances)).
Every name on this page links to a full company dashboard with 5-year SEC financials, live market data, ratios, AI-summarised business description, insider transactions, and institutional ownership. Data is sourced directly from SEC EDGAR XBRL filings and refreshed continuously.